A systematic review and network meta-analysis of 68 studies has found no clear evidence that any specific antipsychotic significantly improves cognitive function in patients with schizophrenia ...
June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...
Verywell Health on MSN
How is schizophrenia treated?
Medically reviewed by Michael MacIntyre, MD Key Takeaways Antipsychotic medication is the cornerstone of treatment for ...
First-Generation Antipsychotic Drugs By Jonathan Scheff This table lists selected first-generation antipsychotic drugs. For a table of atypical agents, click here. For a table of the next generation ...
Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists discuss how first-generation antipsychotics primarily manage positive ...
Oral and parenteral antipsychotics showed similar outcomes in patients with schizophrenia experiencing agitation who presented to the emergency department (ED) with violent behavior, with no ...
Since the first antipsychotic medication, chlorpromazine, was developed in the early 1950s, it could be argued that not all that much has changed in the pharmacological treatment of psychotic ...
After the rapid growth of pediatric antipsychotic prescribing in the early 2000s, especially in the Medicaid population, concerns regarding the safety and appropriateness of such prescribing increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results